Stock data
Pulmonx Corporation (LUNG)
Pulmonx Corporation (LUNG) reported revenue of US$90.50M and net income of -US$54.00M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$90.50M | US$67.14M | -US$53.66M | -US$54.00M | — |
| 2024 | US$83.79M | US$62.00M | -US$57.70M | -US$56.39M | — |
| 2023 | US$68.67M | US$50.75M | -US$61.94M | -US$60.84M | — |
| 2022 | US$53.66M | US$39.87M | -US$58.64M | -US$58.92M | — |
| 2021 | US$48.42M | US$35.63M | -US$47.30M | -US$48.66M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$22.76M | -US$10.08M | — |
| 2026-03-31 | US$20.59M | -US$13.65M | — |
| 2025-12-31 | US$22.60M | -US$10.43M | — |
| 2025-09-30 | US$21.50M | -US$13.96M | — |
| 2025-06-30 | US$23.86M | -US$15.17M | — |
| 2025-03-31 | US$22.54M | -US$14.45M | — |
| 2024-12-31 | US$23.77M | -US$13.18M | — |
| 2024-09-30 | US$20.39M | -US$14.14M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.